Exploiting task and data parallelism in ILUPACK's preconditioned CG solver on NUMA architectures and many-core accelerators

J. Aliaga,Rosa M. Badia,M. Barreda,M. Bollhöfer,Ernesto Dufrechu,P. Ezzatti,E. Quintana-Ortí

DOI: https://doi.org/10.1016/j.parco.2015.12.004

IF: 0.983

2016-05-01

Parallel Computing

Abstract:

What problem does this paper attempt to address?

Desired properties of polymeric hydrogel vitreous substitute

Sheng Qu,Yi Tang,Zichao Ning,Yanjie Zhou,Hong Wu

DOI: https://doi.org/10.1016/j.biopha.2024.116154

IF: 7.419

2024-02-02

Biomedicine & Pharmacotherapy

Abstract:Vitreous replacement is a commonly employed method for treating a range of ocular diseases, including posterior vitreous detachment, complex retinal detachment, diabetic retinopathy, macular hole, and ocular trauma. Various clinical substitutes for vitreous include air, expandable gas, silicone oil, heavy silicone oil, and balanced salt solution. However, these substitutes have drawbacks such as short retention time, cytotoxicity, high intraocular pressure, and the formation of cataracts, rendering them unsuitable for long-term treatment. Polymeric hydrogels possess the potential to serve as ideal vitreous substitutes due to their structure-mimicking to natural vitreous and adjustable mechanical properties. Replacement with hydrogels as the tamponade can help maintain the shape of the eyeball, apply pressure to the detached retina, and ensure the metabolic transport of substances without impairing vision. This literature review examines the required properties of artificial vitreous, including the optical properties, rheological properties, expansive force action, and physiological and biochemical functions of chemically and physically crosslinked hydrogels. The strategies for enhancing the biocompatibility and injectability of hydrogels are also summarized and discussed. From a clinical ophthalmology perspective, this paper presents the latest developments in vitreous replacement, providing clinicians with a comprehensive understanding of hydrogel clinical applications, which offers guidance for future design directions and methodologies for hydrogel development.

pharmacology & pharmacy,medicine, research & experimental
Vitreous Substitutes: The Present and the Future

Simone Donati,Simona Maria Caprani,Giulia Airaghi,Riccardo Vinciguerra,Luigi Bartalena,Francesco Testa,Cesare Mariotti,Giovanni Porta,Francesca Simonelli,Claudio Azzolini

DOI: https://doi.org/10.1155/2014/351804

2014-01-01

BioMed Research International

Abstract:Vitreoretinal surgery has advanced in numerous directions during recent years. The removal of the vitreous body is one of the main characteristics of this surgical procedure. Several molecules have been tested in the past to fill the vitreous cavity and to mimic its functions. We here review the currently available vitreous substitutes, focusing on their molecular properties and functions, together with their adverse effects. Afterwards we describe the characteristics of the ideal vitreous substitute. The challenges facing every ophthalmology researcher are to reach a long-term intraocular permanence of vitreous substitute with total inertness of the molecule injected and the control of inflammatory reactions. We report new polymers with gelification characteristics and smart hydrogels representing the future of vitreoretinal surgery. Finally, we describe the current studies on vitreous regeneration and cell cultures to create new intraocular gels with optimal biocompatibility and rheological properties.

biotechnology & applied microbiology,medicine, research & experimental
A highly transparent tri-polymer complex in situ hydrogel of HA, collagen and four-arm-PEG as potential vitreous substitute

Indu Yadav,Shiv Dutt Purohit,Hemant Singh,Neeladrisingha Das,Partha Roy,Narayan Chandra Mishra,Neeladri Singha Das

DOI: https://doi.org/10.1088/1748-605X/ac2714

2021-10-06

Biomedical Materials (Bristol)

Abstract:There is a requirement of removal and replacement of vitreous for various ophthalmic diseases, e.g. retinopathy and retinal detachment. Clinical tamponades, e.g. silicone oil and fluorinated gases are used but limited due to their toxicity and some complications. A lot of polymer-based materials have been tested and proposed as vitreous substitute, but till date, there is no ideal vitreous substitute available. Thus, it requires to develop an improved vitreous substitute which will be highly suitable for vitreous replacement. We have developed tri-polymer complex in situ hydrogels by crosslinking among hyaluronic acid (HA), collagen (Coll) and four-arm-polyethylene glycol (PEG). All the developed hydrogels are biocompatible with NIH 3T3 mouse fibroblast cells, having pH in the range 7–7.44 and refractive index in the range 1.333–1.345. The developed hydrogels are highly transparent, showing transmittance >97%. FTIR study shows that the hydrogel was crosslinked by amide bond formation between HA and PEG, and between Coll and PEG. The rheological study shows that all the developed hydrogels exhibit viscoelastic behavior and all the hydrogels have storage modulus values (>100 pa) which is greater than loss modulus values—indicating sufficient elasticity for vitreous application. The elastic nature of the hydrogel increases with the increase in PEG concentration. The gel is formed in between 2 and 3 min—indicating its application in situ . The viscosity of the developed hydrogels shows shear thinning behavior. The pre-gel solution of the hydrogel is injectable through a 22 G needle—indicating its application in situ through vitrectomy surgery. All the hydrogels are hydrophilic and have water content of 96% approximately. Thus, the results show the positive properties for its application as a potential vitreous substitute.
Injectable self-assembling peptide hydrogel as a promising vitreous substitute

Yuting Cai,Yatong Xiang,Huilei Dong,Wenjing Huang,Yan Liu,Chenguang Zhao,Dan Yuan,Yun Li,Junfeng Shi

DOI: https://doi.org/10.1016/j.jconrel.2024.10.016

Abstract:Vitreoretinal diseases pose significant threats to vision, often requiring vitrectomy and substitution of vitreous humor to restore ocular structure and visual function. However, existing substitutes have limitations that compromise patient outcomes. Supramolecular hydrogels, particularly peptide-based formulations, have emerged as promising alternatives due to their superior optical clarity, biocompatibility, and viscoelasticity. In this study, we designed and evaluated two peptide hydrogels, 3K-OX and 3E-OX, bearing positive and negative charges, respectively, as potential vitreous substitutes. Our in vitro findings revealed that the physicochemical properties of the negatively charged peptide hydrogel, 3E-OX, closely resembled those of the native vitreous body, exhibiting optimal light transmittance, refractive index, molecular permeability, and biocompatibility. Animal studies further confirmed the safety and biocompatibility of 3E-OX as a promising vitreous substitute. Notably, we introduced optical coherence tomography for retinal microvascular detection in non-pigmented rabbits, presenting a novel approach to evaluate the performance of intraocular tamponade materials. This work not only expands the utility of peptide hydrogels but also provides valuable insights into the design of vitreous substitutes.
Ultrastructure of carotenoid deprivation in photoreceptors of Manduca sexta: myeloid bodies and intracellular microvilli

Richard H. White,R. R. Bennett

DOI: https://doi.org/10.1007/BF00221461

1989-09-01

Cell and Tissue Research

Abstract:
An in situ-forming polyzwitterion hydrogel: Towards vitreous substitute application

Binbin He,Jianhai Yang,Yang Liu,Xianhua Xie,Huijie Hao,Xiaoli Xing,Wenguang Liu

DOI: https://doi.org/10.1016/j.bioactmat.2021.02.029

IF: 18.9

2021-10-01

Bioactive Materials

Abstract:A multivinyl polyzwitterion macromonomer is synthesized.In situ formation of polyzwitterionic hydrogel enables easy operation in surgery.This antifouling hydrogel exhibits approximate parameters to vitreous body.The hydrogel shows excellent biocompatibility in vitreous cavity.Development of a biostable and biosafe vitreous substitute is highly desirable, but remains a grand challenge. Herein, we propose a novel strategy for constructing a readily administered vitreous substitute based on a thiol-acrylate clickable polyzwitterion macromonomer. A biocompatible multivinyl polycarboxybetaine (PCB-OAA) macromonomer is designed and synthesized, and mixed with dithiothreitol (DTT) via a Michael addition reaction to form a hydrogel in vitreous cavity. This resultant PCB-OAA hydrogel exhibits controllable gelation time, super anti-fouling ability against proteins and cells, excellent biocompatibility, and approximate key parameters to human vitreous body including equilibrium water content, density, optical properties, modulus. Remarkably, outperforming clinically used silicone oil in biocompatibility, this rapidly formed hydrogel in the vitreous cavity of rabbit eyes remains stable in vitreous cavity, showing an appealing ability to prevent significantly inflammatory response, fibrosis and complications such as raised intraocular pressure (IOP), and cataract formation. This zwitterionic polymer hydrogel holds great potential as a vitreous substitute.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21000888-fx1_lrg.jpg">Download : Download high-res image (431KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21000888-fx1.jpg">Download : Download full-size image</a></li></ol>

engineering, biomedical,materials science, biomaterials
Evaluation of an in Situ Chemically Crosslinked Hydrogel As a Long-Term Vitreous Substitute Material.

Yong Tao,Xinming Tong,Yan Zhang,Jingjing Lai,Yanbin Huang,Yan-Rong Jiang,Bao-Hua Guo

DOI: https://doi.org/10.1016/j.actbio.2012.09.026

IF: 10.633

2012-01-01

Acta Biomaterialia

Abstract:Currently there is no material that can be used as a long-term vitreous substitute, and this remains an unmet clinical need in ophthalmology. In this study, we developed an injectable, in situ chemically crosslinked hydrogel system and evaluated it in a rabbit model. The system consisted of two components, both based on multi-functional poly(ethylene glycol) (PEG) but with complementarily reactive end groups of thiol and active vinyl groups, respectively. The two components are mixed and injected as a solution mixture, react in vivo via the Michael addition route and form a chemically crosslinked hydrogel in situ. The linkages between the end groups and the backbone PEG chains are specially designed to ensure that the final network structure is hydrolysis-resistant. In the rabbit study and with an optimized operation protocol, we demonstrated that the hydrogel indeed formed in situ after injection, and remained transparent and stable during the study period of 9 months without significant adverse reactions. In addition, the hydrogel formed in situ showed rheological properties very similar to the natural vitreous. Therefore, our study demonstrated that this in situ chemically crosslinked PEG gel system is suitable as a potential long-term vitreous substitute.
Recent Advances in Hydrogels: Ophthalmic Applications in Cell Delivery, Vitreous Substitutes, and Ocular Adhesives

Athena Wang,Janaki Iyer,Kenny T. Lin,Alexandra B. Nguyen,Simon D. Tran

DOI: https://doi.org/10.3390/biomedicines9091203

IF: 4.757

2021-09-12

Biomedicines

Abstract:With the prevalence of eye diseases, such as cataracts, retinal degenerative diseases, and glaucoma, different treatments including lens replacement, vitrectomy, and stem cell transplantation have been developed; however, they are not without their respective shortcomings. For example, current methods to seal corneal incisions induced by cataract surgery, such as suturing and stromal hydration, are less than ideal due to the potential for surgically induced astigmatism or wound leakage. Vitrectomy performed on patients with diabetic retinopathy requires an artificial vitreous substitute, with current offerings having many shortcomings such as retinal toxicity. The use of stem cells has also been investigated in retinal degenerative diseases; however, an optimal delivery system is required for successful transplantation. The incorporation of hydrogels into ocular therapy has been a critical focus in overcoming the limitations of current treatments. Previous reviews have extensively documented the use of hydrogels in drug delivery; thus, the goal of this review is to discuss recent advances in hydrogel technology in surgical applications, including dendrimer and gelatin-based hydrogels for ocular adhesives and a variety of different polymers for vitreous substitutes, as well as recent advances in hydrogel-based retinal pigment epithelium (RPE) and retinal progenitor cell (RPC) delivery to the retina.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Coagulation of Ventricular Myocardium Using Radiofrequency Alternating Current: Bio‐Physical Aspects and Experimental Findings

W. Haverkamp,G. Hindricks,Hartmut Gulker,U. Rissel,W. Pfennings,M. Borggrefe,G. Breithardt

DOI: https://doi.org/10.1111/j.1540-8159.1989.tb02646.x

1989-01-01

Abstract:Within the last years, a variety of different energy sources has been investigated to test their feasibilty for catheter ablation of myocardial tissue. This report summarizes our experience of the use of radiofrequency alternating current (500 kHz, unipolar mode) for coagulation of ventricular myocardium in canine experiments. Under standardized in vitro conditions, we found a significant correlation between actually delivered radiofrequency energy and assesed myocardial necrosis (r = 0.87). However, this did not hold for percutaneous application of radiofrequency alternating current to the beating dog heart (r = 0.32). In the intact dog heart, the size of induced lesions paralleled catheter contact pressure which was varied until ST‐egment elevation was either 0–2 mV or 5–7 mV. However, no statistical significant differences in either calculated energy or tissue impedance were observed. Under in vivo conditions, a significant improvement in the predictability of the resulting size of lesions was observed when catheter tip temperature, measured via a built‐in Ni/CrNi thermoelement, was monitored (r = 0.07). Changes in tip temperature during coagulation also indicated the quality of catheter contact, catheter damage and the appearance of carbonization at the tip of the ablation catheter. Total perforation of the myocardial wall and proarrhythmogenic effects were only rarely observed. In conclusion, catheter coagulation of myocardial tissue using radiofrequency energy can be considered as safe and effective. Since changes in catheter tip temperature occurring during coagulation were found to predict the extent of induced tissue necrosis, the development of temperature controlled radiofrequency devices seems promising and necessary.
An in Situ-Forming Zwitterionic Hydrogel As Vitreous Substitute

Jing Chang,Yong Tao,Bin Wang,Bao-hua Guo,Hong Xu,Yan-rong Jiang,Yanbin Huang

DOI: https://doi.org/10.1039/c4tb01775g

IF: 7.571

2015-01-01

Journal of Materials Chemistry B

Abstract:Zwitterionic polymers have shown ultra-low biofouling properties at surfaces and excellent biocompatibility as implant. In this study, an in situ-forming zwitterionic hydrogel was designed and evaluated, both in vitro and in vivo, as a long-term vitreous substitute. The zwitterionic polymer poly(MPDSA-co-AC) was designed as a copolymer of the sulfobetaine methacrylamide and acryloyl cystamine monomers, providing the zwitterionic components and the thiol functional groups, respectively. The in situ gelation was via the thiol-ene Michael addition reaction with α-PEG-MA as the crosslinker. The gelation time, rheological properties, swelling profiles, and the transparency of zwitterionic hydrogels were studied in detail. Two systems with different crosslinker concentrations were tested in a rabbit model, and the one with the thiol-ene ratio of 2 : 1 showed excellent biocompatibility in vivo, formed space-filling hydrogels and remained transparent in the vitreous cavity for the 2 month implantation period. Therefore, in situ-forming zwitterionic hydrogels represent a promising material system as a vitreous substitute and possibly for other soft tissue replacements.
DNA Supramolecular Hydrogel as a Biocompatible Artificial Vitreous Substitute

Yu Jin,Yujie Li,Sijia Song,Yuqiao Ding,Yuanchen Dong,Yao Lu,Dongsheng Liu,Chun Zhang

DOI: https://doi.org/10.1002/admi.202101321

IF: 5.4

2021-12-26

Advanced Materials Interfaces

Abstract:Pars plana vitrectomy plays an important role in treating serious ophthalmic diseases, which requires subsequent substitution of the natural vitreous. However, the current substitutes are known for the drawbacks in instability, toxicity, and injection‐induced fragmentation, so there is a very urgent need in novel artificial vitreous substitute for clinical practice. In this study, DNA supramolecular hydrogel is evaluated as a potential artificial vitreous substitute. It is observed that DNA supramolecular hydrogel exhibits relatively strong mechanical strength, shear‐thinning behavior, rapid recoverability, and other physical properties similar to the human vitreous body. The in vivo experiments further prove the injectability, excellent biocompatibility, and in vivo stability. With the support of the DNA supramolecular hydrogel, the morphology and basic functions of the operated eyes are well recovered without obvious inflammation, which demonstrate the DNA supramolecular hydrogel shows enormous potential as vitreous substitute. DNA supramolecular hydrogel has been applied as a potential artificial vitreous substitute for the first time, which exhibits excellent biocompatibility and in vivo stability without obvious inflammation, providing a novel platform for the artificial vitreous.

materials science, multidisciplinary,chemistry
Evaluation of a Redox-Initiated in Situ Hydrogel As Vitreous Substitute

Jing Chang,Yong Tao,Bin Wang,Xiaotong Yang,Hong Xu,Yan-rong Jiang,Bao-Hua Guo,Yanbin Huang

DOI: https://doi.org/10.1016/j.polymer.2014.07.031

IF: 4.6

2014-01-01

Polymer

Abstract:Currently there is no material clinically available as a long-term vitreous substitute. In this study, an insitu gelation system based on alpha-poly(ethylene glycol) methacrylate (alpha-PEG-MA) and a redox-initiated radical polymerization/crosslinking reaction was evaluated for this purpose. Ammonium persulfate CAPS) and N,N,N',N'-tetramethyl ethylene diamine (TMEDA) were used as initiators. The gelation time, rheological properties, reaction kinetics and swelling profiles were studied in detail and the system with 10 wt% of alpha-PEG-MA and 8 mM APS/TMEDA was chosen as the optimal material for in vivo studies. Using the rabbit as the animal model, we showed that the system did form a space-filling and transparent gel in the vitreous cavity, and the inflammation response could be controlled to an acceptable level. (C) 2014 Elsevier Ltd. All rights reserved.
Eye of the future: Unlocking the potential utilization of hydrogels in intraocular lenses

Hao Wu,Jiale Wang,Wenhui Fan,Qi Zhong,Rongyue Xue,Siyu Li,Zongming Song,Ye Tao

DOI: https://doi.org/10.1002/btm2.10664

2024-04-25

Bioengineering & Translational Medicine

Abstract:Hydrogels are distinguished by their exceptional ability to absorb and retain large volumes of water within their complex three‐dimensional polymer networks, which is advantageous for the development of intraocular lenses (IOLs). Their innate hydrophilicity offers an optimal substrate for the fabrication of IOLs that simulate the natural lens' accommodation, thereby reducing irritation and facilitating healing after surgery. The swelling and water retention characteristics of hydrogels contribute to their notable biocompatibility and versatile mechanical properties. However, the clinical application of hydrogels faces challenges, including managing potential adverse postimplantation effects. Rigorous research is essential to ascertain the safety and effectiveness of hydrogels. This review systematically examines the prospects and constraints of hydrogels as innovative materials for IOLs. Our comprehensive analysis examines their inherent properties, various classification strategies, cross‐linking processes, and sensitivity to external stimuli. Additionally, we thoroughly evaluate their interactions with ocular tissues, underscoring the potential for hydrogels to be refined into seamless and biologically integrated visual aids. We also discuss the anticipated technological progress and clinical uses of hydrogels in IOL manufacturing. With ongoing technological advancements, the promise of hydrogels is poised to evolve from concept to clinical reality, marking a significant leap forward in ophthalmology characterized by improved patient comfort, enhanced functionality, and reliable safety.

engineering, biomedical
Functionalized hydrogels in ophthalmic applications: Ocular inflammation, corneal injuries, vitreous substitutes and intravitreal injection

Qiaoyun Gong,Yue Zhao,Tianwei Qian,Haiyan Wang,Zuhao Li

DOI: https://doi.org/10.1016/j.matdes.2022.111277

2022-12-01

Abstract:With the prevalence of eye diseases, such as inflamed eyes, corneal injury, cataract, glaucoma, and retinal degenerative diseases, different clinical strategies have been developed, however, they still suffer from many inevitable drawbacks in practical applications. Functionalized hydrogels have emerged as attractive materials and revolutionary strategies for ophthalmic applications owing to their favorable properties, such as excellent biocompatibility, near-physiological extracellular matrix environment, injectability, tailorable structure, inherent flexibility, dynamically adjustable mechanical properties, particularly attractive self-adhesion, enviable cell delivery, and sustained drug release capabilities. In this review, various functionalized hydrogels for different ophthalmic diseases have been comprehensively summarized. The review also systematically introduces the advanced research progress in ophthalmic applications, including topical administration for superficial inflamed eyes, dressings for corneal injuries, injectable drug delivery system for glaucomatous optic neuropathy, vitreous substitutes after vitrectomy, intravitreal administration for intraocular diseases, and etc. Finally, the scientific challenges and untapped potential are expounded to demonstrate the future prospects of engineered hydrogels for the treatment of ocular diseases. The review aims to provide comparative perspectives and multifaceted insights to inspire more in-depth research on hydrogels and provide guidance for their varied applications in ophthalmology.

materials science, multidisciplinary
In Vivo Assessment of an Antioxidant Hydrogel Vitreous Substitute

Megan M. Allyn,Annie K. Ryan,Grace Rivera,Esther Mamo,Joshua Bopp,Sebastian Martinez Hernandez,Julie Racine,Eric J. Miller,Heather L. Chandler,Katelyn E. Swindle‐Reilly

DOI: https://doi.org/10.1002/jbm.a.37813

2024-11-01

Journal of Biomedical Materials Research Part A

Abstract:The vitreous humor undergoes liquefaction with age, resulting in complications that may require a vitrectomy, or surgical removal of the vitreous from the eye. Silicone oil, a common vitreous substitute, lacks properties similar to the natural vitreous. In particular, it lacks antioxidants that may be necessary to reduce oxidative stress in the eye. The purpose of this study was to evaluate antioxidant‐loaded hydrogel vitreous substitutes in a pilot in vivo study. Ascorbic acid and glutathione were loaded into synthesized PEGDA hydrogels. Following vitrectomy, experimental antioxidant hydrogels or silicone oil were injected into one eye of rabbits, while the other eye served as untreated or sham control. Ophthalmic assessments, including electroretinography, were performed. Levels of glutathione and ascorbic acid were higher in the eyes treated with the antioxidant‐loaded hydrogel vitreous substitute, although this was not found to be significant after 28 days. There were no statistically significant differences between groups with respect to clinical examination, and ocular health scores, electroretinograms, and histology were normal. These results indicate minimal concerns for the hydrogel formulation or high levels of antioxidants. Future research will assess the capability of vitreous substitutes to prolong antioxidant release, with the goal of minimizing cataract after vitrectomy.

engineering, biomedical,materials science, biomaterials
Injectable alginate-based In situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function

Geunho Choi,Seoung Hyun An,Jae-Won Choi,Mee Sook Rho,Woo Chan Park,Woo jin Jeong,Hyung Joon Cha

DOI: https://doi.org/10.1016/j.biomaterials.2023.122459

IF: 14

2024-01-03

Biomaterials

Abstract:Retinal detachment and other vision-threatening disorders often necessitate vitreous body removal and tamponade injection for retina stabilization. Current clinical tamponades such as silicone oil and expansile gases have drawbacks, including patient discomfort and the need for secondary surgery. We introduce a transparent alginate-phenylboronic acid/polyvinyl alcohol composite hydrogel (TALPPH) as a novel vitreous substitute with tamponading capabilities. In vitro physicochemical, rheological, and optical characterization of in situ self-healable TALPPH was performed, and long-term biocompatibility was assessed in a rabbit model of vitrectomy retinal detachment. In vivo evaluations confirmed TALPPH's ability to inhibit retinal detachment recurrence and preserve rabbit vision without adverse effects. TALPPH's close resemblance to the natural vitreous body suggests potential as a vitreous tamponade substitute for future ophthalmological applications.

engineering, biomedical,materials science, biomaterials
Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment

Sven Schnichels,Nele Schneider,Christine Hohenadl,José Hurst,Andreas Schatz,Kai Januschowski,Martin S Spitzer

DOI: https://doi.org/10.1371/journal.pone.0172895

IF: 3.7

2017-03-01

PLoS ONE

Abstract:The efficacy of two novel artificial vitreous body substitutes (VBS) consisting of highly biocompatible thiolated cross-linked hyaluronic acid (HA)-based hydrogels in comparison to silicone oil in a model of retinal detachment was investigated. Pars plana vitrectomy (23G) was performed in the right eye of 24 pigmented rabbits. Retinal detachment of two quadrants was induced by creating a small retinotomy near the vascular arcade and injecting balanced salt solution (BSS) subretinally. The retina was reattached by injecting air, which was followed by increasing the infusion pressure, and the retinal tear was treated by endolaser photocoagulation. At the end of the procedure, the eye was filled either with 5000-cs silicone oil (after fluid air exchange) or the respective hydrogel (with two different viscosities). Follow-up examination included slit lamp examination, funduscopy, intraocular pressure measurements (IOP), optical coherence tomography (OCT) and electroretinogram (ERG) measurements. After a maximum follow-up of four weeks both eyes were removed, examined macroscopically, photographed, and prepared for histology. Of the eight rabbits that received silicone oil, seven (87.5%) developed a recurrent retinal detachment with pronounced proliferative vitreoretinopathy within the first two weeks after surgery. In contrast, in the hydrogel treated eyes, the retina stayed attached in the majority of the cases (73.3%). IOP and retinal morphology were normal as long as the retina remained re-attached. In conclusions, this model of retinal detachment, both thiolated crosslinked hyaluronate hydrogels showed superior efficacy when compared to silicone oil. These hydrogels have a promising potential as novel vitreous body substitutes.
Injectable cross-linked hyaluronic acid hydrogels with epigallocatechin gallate loading as vitreous substitutes

Huai-An Chen,Yi-Ning Tai,Erh-Hsuan Hsieh,Minal Thacker,I-Chan Lin,Ching-Li Tseng,Feng-Huei Lin

DOI: https://doi.org/10.1016/j.ijbiomac.2024.133467

Abstract:Hyaluronic acid (HA) serves as a vitreous substitute owing to its ability to mimic the physical functions of native vitreous humor. However, pure HA hydrogels alone do not provide sufficient protection against potential inflammatory risks following vitrectomy. In this study, HA was crosslinked with 1,4-butanediol diglycidyl ether (BDDE) to form HA hydrogels (HB). Subsequently, the anti-inflammatory agent epigallocatechin gallate (EGCG) was added to the hydrogel (HBE) for ophthalmic applications as a vitreous substitute. The characterization results indicated the successful preparation of HB with transparency, refractive index, and osmolality similar to those of native vitreous humor, and with good injectability. The anti-inflammatory ability of HBE was also confirmed by the reduced expression of inflammatory genes in retinal pigment epithelial cells treated with HBE compared with those treated with HB. In a New Zealand white rabbit model undergoing vitreous substitution treatment, HBE 50 (EGCG 50 μM addition) exhibited positive results at 28 days post-surgery. These outcomes included restored intraocular pressure, improved electroretinogram responses, minimal increase in corneal thickness, and no inflammation during histological examination. This study demonstrated the potential of an injectable HA-BDDE cross-linked hydrogel containing EGCG as a vitreous substitute for vitrectomy applications, offering prolonged degradation time and anti-inflammatory effects postoperatively.
Detection and assessment of laser-mediated injury in transmyocardial revascularization.

P. Whittaker

DOI: https://doi.org/10.1089/CLM.1997.15.261

1997-12-01

Journal of Clinical Laser Medicine & Surgery

Abstract:When channels are made through the myocardium with a laser, tissue surrounding the channels is injured. Thus, methods of examining and quantifying the histologic changes caused by laser-mediated injury are required both for comparison of different channel making protocols and also to help understand the mechanisms of transmyocardial revascularization. The two principal components of the myocardium, collagen and muscle, are both normally birefringent. This optical property can be exploited with the use of polarized light microscopy to assess tissue structure at the cellular and subcellular levels allowing several different types of injury to be detected. Increases in tissue temperature above 60 degrees C for muscle and 70 degrees C for collagen decrease their birefringence and, hence, result in decreased brightness when viewed with polarized light. Lower temperatures may cause cell membrane injury, calcium overload, and the formation of contraction bands, which appear as areas of increased birefringence. In this way, the extent of thermal injury can be assessed. The same optical properties can be used to measure cell and fiber orientation and, hence, enable assessment of mechanical disruption of the tissue after ablation. Long-term remodeling of the myocardium in the form of scar formation, increased interstitial fibrosis, and muscle disarray can also be quantified. The ability to measure the acute injury and the long-term structural consequences of that injury with the use of polarized light microscopy should prove vital in determining the optimal laser "dose" required and may also reveal information on the mechanism(s) of benefit found with transmyocardial revascularization.
Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems

Kevin Y Wu,Sameer Khan,Zhuoying Liao,Michael Marchand,Simon D Tran

DOI: https://doi.org/10.3390/polym16121717

2024-06-16

Abstract:The interface between material science and ophthalmic medicine is witnessing significant advances with the introduction of biopolymers in medical device fabrication. This review discusses the impact of biopolymers on the development of ophthalmic devices, such as intraocular lenses, stents, and various prosthetics. Biopolymers are emerging as superior alternatives due to their biocompatibility, mechanical robustness, and biodegradability, presenting an advance over traditional materials with respect to patient comfort and environmental considerations. We explore the spectrum of biopolymers used in ophthalmic devices and evaluate their physical properties, compatibility with biological tissues, and clinical performances. Specific applications in oculoplastic and orbital surgeries, hydrogel applications in ocular therapeutics, and polymeric drug delivery systems for a range of ophthalmic conditions were reviewed. We also anticipate future directions and identify challenges in the field, advocating for a collaborative approach between material science and ophthalmic practice to foster innovative, patient-focused treatments. This synthesis aims to reinforce the potential of biopolymers to improve ophthalmic device technology and enhance clinical outcomes.

Exploiting task and data parallelism in ILUPACK's preconditioned CG solver on NUMA architectures and many-core accelerators

Desired properties of polymeric hydrogel vitreous substitute

Vitreous Substitutes: The Present and the Future

A highly transparent tri-polymer complex in situ hydrogel of HA, collagen and four-arm-PEG as potential vitreous substitute

Injectable self-assembling peptide hydrogel as a promising vitreous substitute

Ultrastructure of carotenoid deprivation in photoreceptors of Manduca sexta: myeloid bodies and intracellular microvilli

An in situ-forming polyzwitterion hydrogel: Towards vitreous substitute application

Evaluation of an in Situ Chemically Crosslinked Hydrogel As a Long-Term Vitreous Substitute Material.

Recent Advances in Hydrogels: Ophthalmic Applications in Cell Delivery, Vitreous Substitutes, and Ocular Adhesives

Coagulation of Ventricular Myocardium Using Radiofrequency Alternating Current: Bio‐Physical Aspects and Experimental Findings

An in Situ-Forming Zwitterionic Hydrogel As Vitreous Substitute

DNA Supramolecular Hydrogel as a Biocompatible Artificial Vitreous Substitute

Evaluation of a Redox-Initiated in Situ Hydrogel As Vitreous Substitute

Eye of the future: Unlocking the potential utilization of hydrogels in intraocular lenses

Functionalized hydrogels in ophthalmic applications: Ocular inflammation, corneal injuries, vitreous substitutes and intravitreal injection

In Vivo Assessment of an Antioxidant Hydrogel Vitreous Substitute

Injectable alginate-based In situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function

Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment

Injectable cross-linked hyaluronic acid hydrogels with epigallocatechin gallate loading as vitreous substitutes

Detection and assessment of laser-mediated injury in transmyocardial revascularization.

Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems